In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Liposome Company files for Canadian Evacet approval
The Liposome Company and Bristol-Myers Squibb collaborate on combination therapy trials
Liposome's Evacet filing accepted in Europe: trial collaboration with RPR
Valentis initiates gene therapy clinical trial
Elan to acquire The Liposome Company
CytoGenix and Endovasc begin cooperative research
The Liposome Company receives regulatory approval for Abelcet
Duke University grants Celsion exclusive liposome license
NeoPharm terminates license agreement with Pharmacia
Cantab exercises option to license Novavax liposome adjuvants